Literature DB >> 7996840

Human endothelial cells are defective in diabetic vascular disease.

A Sank1, D Wei, J Reid, D Ertl, M Nimni, F Weaver, A Yellin, T L Tuan.   

Abstract

Diabetic vascular disease is characterized pathologically by endothelial cell (EC) hyperplasia and basement membrane (BM) thickening. One key question regarding the pathogenesis of diabetic vascular disease is whether the EC or BM or both are primarily defective and responsible for these pathological changes. Previous studies, which took the approach of creating artificial diabetic conditions, have been inconclusive. It is known, however, that the extracellular matrix may be altered by glycosylation as a result of hyperglycemia, thereby altering EC function. To begin to address this question and more closely mimic the situation in vivo, we characterized human diabetic EC harvested from insulin-dependent diabetic mothers (IDDM) at the cellular and molecular levels. Human EC were isolated from both normal and IDDM umbilical cords and cellular functions evaluated using standard assays of attachment (% attached cells), proliferation (cpm/cell), resistance to detachment under shear stress (number of cells remaining attached), and glucose uptake (cpm/2 X 10(4) cells). Gene expression of major BM components (collagen type IV, laminin beta 1, and laminin beta 2) was quantified by Northern analysis. Diabetic EC demonstrated increased proliferation (two- to eightfold compared to normals), were 20-40% less resistant to shear stress and took up glucose 10-15% more slowly than normal EC. Furthermore, Northern analysis showed that the expression of major BM components was increased by an average of 10-18% in diabetic cells compared to normal cells. These results were consistent with in vivo observations and previously published data.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996840     DOI: 10.1006/jsre.1994.1195

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction.

Authors:  Shubha Varma; Brajesh K Lal; Ruifang Zheng; Jerome W Breslin; Satoshi Saito; Peter J Pappas; Robert W Hobson; Walter N Durán
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-06-17       Impact factor: 4.733

2.  Elevated D-glucose induces insulin insensitivity in human umbilical endothelial cells isolated from gestational diabetic pregnancies.

Authors:  L Sobrevia; D L Yudilevich; G E Mann
Journal:  J Physiol       Date:  1998-01-01       Impact factor: 5.182

3.  Ablation of NF-kappaB expression by small interference RNA prevents the dysfunction of human umbilical vein endothelial cells induced by high glucose.

Authors:  Gang Chen; Xiaoyan Shen; Jin Yao; Feng Chen; Xu Lin; Yufang Qiao; Tingting You; Fenghui Lin; Xiaowen Fang; Xin Zou; Lixiang Lin
Journal:  Endocrine       Date:  2008-11-08       Impact factor: 3.633

4.  Structural alterations of the glomerular wall and vessels in early stages of diabetes mellitus: (light and transmission electron microscopic study).

Authors:  Allah R S Awad; M A Dkhil; M A Danfour
Journal:  Libyan J Med       Date:  2007-09-01       Impact factor: 1.657

5.  Endothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor.

Authors:  Juying Han; Anil K Mandal; Linda M Hiebert
Journal:  Cardiovasc Diabetol       Date:  2005-08-09       Impact factor: 9.951

6.  Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19?

Authors:  Noé Alvarado-Vasquez
Journal:  Med Hypotheses       Date:  2020-11-06       Impact factor: 1.538

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.